UPC Analytics
ENDE
Overview · Filed:

CC_585030/2023

A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

Parent infringement case:UPC_CFI_15/2023

RevocationCounter Claim for RevocationParis CDCounterclaim for revocation
Parties

Claimants

Reps: Emmanuel Larere (Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Gide Loyrette Nouel AARPI); Jean-Robert Callon de Lamarck (Regimbeau); Anne Seibel (Regimbeau); Andreas von Falck (Hogan Lovells International LLP)

Respondents

Reps: Boris Kreye (Bird & Bird LLP); Elsa Tzschoppe (Bird & Bird LLP); Bernhard Thum (Thum & Partner); Jonas Weickert (Thum & Partner); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP); Bryce Matthewson (Powell Gilbert (Europe) LLP)
Judges

French-seated division — individual judges anonymized.

  • Panel member (anonymized)Presiding judge and judge-rapporteur
  • Panel member (anonymized)Legally qualified judge
  • Panel member (anonymized)Technically qualified judge
Patents
  • EP 3 646 825
CPC codes: A61F2220/0075, A61F2/2436, A61F2250/0065, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2433

Technology area: Medical Devices · Implants

Sector: Pharmaceutical & Medical

Outcome
Patent amendedMaintained as amended
Filed:
First decided: Jul 19, 2024
Language:

Decision of the Paris Central Division rejecting the revocation action by Meril Italy Srl and the counterclaims for revocation by Meril GmbH and Meril Life Sciences Pvt Ltd against Edwards Lifesciences Corporation's EP 3 646 825 (prosthetic heart valve). The patent is maintained as amended in auxiliary request II, which limits claims to a frame made up entirely of hexagonal cells. The revocation claimants (60%) and defendant (40%) share costs.

Claims
At issueall
Amendedall
Notes: Counterclaim for revocation by Meril GmbH/Meril Life Sciences against EP3646825; same decision as ACT_551308/2023 — patent maintained in amended form per auxiliary request II; specific amended claim 1 text reproduced in excerpt.